Literature DB >> 17180440

Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue.

Gulsah Kaygusuz1, Ozden Tulunay, Sumer Baltaci, Orhan Gogus.   

Abstract

The aim of this study was to investigate the relationship between microvessel density (MVD), positive and negative angiogenic factors, and established prognostic factors in prostate cancer (PC), and, to clarify the effect of angiogenic factors to angiogenesis. The vascularization of neoplastic, non-neoplastic prostate tissue was determined by CD34 immunostaining. Angiogenetic mediators VEGF, bFGF, TSP-1, and p53 were studied by immunohistochemistry. Neovascularization and p53, VEGF, and TSP-1 expressions of tumorous tissue were higher than non-tumorous tissue. The bFGF expression in these tissues was not different. The p53 expression was not correlated with the expressions of VEGF, bFGF, and TSP-1 in PC. Our results demonstrate a significant increase in MVD, VEGF, TSP-1, and p53 expressions in prostate tumorigenesis. The pretreatment sPSA was the only parameter demonstrating significant correlation with tumor grade and may have a value in the prediction of aggressive tumor behavior in PC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17180440     DOI: 10.1007/s11255-006-9144-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  45 in total

1.  Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro.

Authors:  M L Iruela-Arispe; P Bornstein; H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 2.  Angiogenesis: models and modulators.

Authors:  G W Cockerill; J R Gamble; M A Vadas
Journal:  Int Rev Cytol       Date:  1995

Review 3.  The cell biology of thrombospondin-1.

Authors:  H Chen; M E Herndon; J Lawler
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

4.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

5.  Radical retropubic prostatectomy for localised prostatic carcinoma: a clinical and pathological study of 201 cases.

Authors:  K V Pedersen; A Herder
Journal:  Scand J Urol Nephrol       Date:  1993

6.  Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas.

Authors:  M Streit; P Velasco; L F Brown; M Skobe; L Richard; L Riccardi; J Lawler; M Detmar
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 7.  The prostate: diagnostic evaluation of metastatic disease.

Authors:  K K Yu; R A Hawkins
Journal:  Radiol Clin North Am       Date:  2000-01       Impact factor: 2.303

8.  Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia.

Authors:  C Kwak; R J Jin; C Lee; M S Park; S E Lee
Journal:  BJU Int       Date:  2002-02       Impact factor: 5.588

9.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

10.  Late local complications after definitive radiotherapy for prostatic adenocarcinoma.

Authors:  J G Moreno; T E Ahlering
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

View more
  7 in total

1.  Assessment of prostate cancer with integrated CT-perfusion using a sector-wise approach.

Authors:  Matteo Ferrari; Martin Huellner; Chantal Pauli; Burkhardt Seifert; Hansjörg Danuser; Patrick Veit-Haibach; Agostino Mattei
Journal:  Turk J Urol       Date:  2017-05-03

2.  Use of genetic immunization to generate a high-level antibody against rat dicarboxylate transporter.

Authors:  Guoshuang Xu; An Liu; Xiaowei Liu
Journal:  Int Urol Nephrol       Date:  2008-08-09       Impact factor: 2.370

3.  Combined Dynamic Alterations in Urinary VEGF Levels and Tissue ADAM9 Expression as Markers for Lethal Phenotypic Progression of Prostate Cancer.

Authors:  Chen-Chin Pen; Che-Ming Liu; Cho-Chin Lin; Chia-Chen Lin; Teng-Fu Hsieh; Sajni Josson; Yun-Chi He; Leland W K Chung; Keh-Liang Lin; Shian-Ying Sung
Journal:  Chin J Physiol       Date:  2012-12-31       Impact factor: 1.764

4.  Angiogenesis in Paget's Disease of the Vulva and the Breast: Correlation with Microvessel Density.

Authors:  Patricia E Ellis; Allan B Maclean; L F Wong Te Fong; Julie C Crow; Christopher W Perrett
Journal:  J Oncol       Date:  2012-03-26       Impact factor: 4.375

Review 5.  Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Int J Mol Sci       Date:  2013-06-07       Impact factor: 5.923

6.  Correlation between TSP-1, TGF-β and PPAR-γ expression levels and glioma microvascular density.

Authors:  Jing Zhang; Wei Yang; Duanyun Zhao; Yun Han; Bo Liu; Hua Zhao; Hongbo Wang; Quanzhong Zhang; Guangming Xu
Journal:  Oncol Lett       Date:  2013-10-29       Impact factor: 2.967

7.  Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer.

Authors:  Kathrin Endt; Jens Goepfert; Aurelius Omlin; Alcibiade Athanasiou; Pierre Tennstedt; Anna Guenther; Maurizio Rainisio; Daniel S Engeler; Thomas Steuber; Silke Gillessen; Thomas Joos; Ralph Schiess
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.